“We are pleased to have a professional with Jim Havel’s financial and operational expertise, as well as proven experience with Express Scripts, to lead our finance function and manage a seamless transition,” said Tim Wentworth, Chief Executive Officer and President of Express Scripts. “Given our Enterprise Value Initiative, the eviCore transaction and the dynamic nature of our industry, we are fortunate to have someone in the CFO position who understands our business and can make an immediate contribution.  Jim is that person.”

Wentworth thanked Slusser for his leadership and his contributions to the company’s success. “Eric has been a strong steward of our shareholders’ financial resources and played an integral role in developing our Enterprise Value Initiative and the eviCore transaction,” he added. “More importantly, Eric built out a strong finance team that has laid a solid foundation for our long-term success.”

Havel joined Express Scripts in January 2015 and served as the Company’s Interim Chief Financial Officer until September 2015. Before joining Express Scripts, Havel served as Chief Financial Officer of Major Brands Holdings, a privately-held beverage distribution company. He also spent more than 34 years with Ernst & Young LLP, where he began his career in 1976. During his time with Ernst & Young LLP, Havel served as an audit partner and in a number of firm leadership roles, including as managing partner of two different offices. Havel is a member of the board of directors of Enterprise Financial Services Corp. and is a Certified Public Accountant.

About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

Investor Contact
Ben Bier
[email protected]

Media Contacts
Phil Blando
[email protected]

Jennifer Luddy
[email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/express-scripts-appoints-james-m-havel-chief-financial-officer-300542508.html

SOURCE Express Scripts

Related Links


Powered by WPeMatico